109 related articles for article (PubMed ID: 12546960)
21. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia.
Aleskog A; Höglund M; Pettersson J; Hermansson M; Larsson R; Lindhagen E
Leuk Res; 2005 Sep; 29(9):1079-81. PubMed ID: 16038735
[TBL] [Abstract][Full Text] [Related]
23. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.
Arrigoni P; Beretta C; Silvestri D; Rossi V; Rizzari C; Valsecchi MG; Cazzaniga G; Biondi A
Br J Haematol; 2003 Jan; 120(1):89-92. PubMed ID: 12492581
[TBL] [Abstract][Full Text] [Related]
24. No correlation between trisomy 13 and FLT3 duplication in acute myeloid leukemia.
Powell H; Curtis A; Bown N; Taylor P
Cancer Genet Cytogenet; 2005 Jan; 156(1):92-3. PubMed ID: 15588866
[No Abstract] [Full Text] [Related]
25. MLL partial tandem duplications in acute leukemia cell lines.
Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
Leukemia; 2003 May; 17(5):980-1. PubMed ID: 12750714
[No Abstract] [Full Text] [Related]
26. Small molecule FLT3 tyrosine kinase inhibitors.
Levis M; Small D
Curr Pharm Des; 2004; 10(11):1183-93. PubMed ID: 15078134
[TBL] [Abstract][Full Text] [Related]
27. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia.
Horiike S; Yokota S; Nakao M; Iwai T; Sasai Y; Kaneko H; Taniwaki M; Kashima K; Fujii H; Abe T; Misawa S
Leukemia; 1997 Sep; 11(9):1442-6. PubMed ID: 9305595
[TBL] [Abstract][Full Text] [Related]
28. Genomic structure of human FLT3: implications for mutational analysis.
Abu-Duhier FM; Goodeve AC; Wilson GA; Care RS; Peake IR; Reilly JT
Br J Haematol; 2001 Jun; 113(4):1076-7. PubMed ID: 11442505
[No Abstract] [Full Text] [Related]
29. Novel FLT3 tyrosine kinase inhibitors.
Levis M; Small D
Expert Opin Investig Drugs; 2003 Dec; 12(12):1951-62. PubMed ID: 14640939
[TBL] [Abstract][Full Text] [Related]
30. FLT3 inhibition as tailored therapy for acute myeloid leukemia.
Martinelli G; Piccaluga PP; Lo Coco F
Haematologica; 2003 Jan; 88(1):4-8. PubMed ID: 12551818
[No Abstract] [Full Text] [Related]
31. Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway.
Yao Q; Nishiuchi R; Kitamura T; Kersey JH
Leukemia; 2005 Sep; 19(9):1605-12. PubMed ID: 16034464
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
33. AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication.
Takahashi S; Harigae H; Kameoka J; Sasaki T; Kaku M
Br J Haematol; 2005 Aug; 130(3):428-36. PubMed ID: 16042694
[TBL] [Abstract][Full Text] [Related]
34. [New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].
Shiotsu Y
Rinsho Ketsueki; 2008 Aug; 49(8):641-9. PubMed ID: 18800614
[No Abstract] [Full Text] [Related]
35. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA
Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760
[TBL] [Abstract][Full Text] [Related]
36. The American Society of Hematology--46th Annual Meeting and Exposition. HDAC, Flt and farnesyl transferase inhibitors.
Evans L
IDrugs; 2005 Jan; 8(1):4-6. PubMed ID: 15650931
[No Abstract] [Full Text] [Related]
37. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome.
Au WY; Fung AT; Ma ES; Liang RH; Kwong YL
Cancer Genet Cytogenet; 2004 Mar; 149(2):169-72. PubMed ID: 15036894
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.
Choi Y; Kim HJ; Park BH; Min WS; Kim CC
Leukemia; 2005 Jan; 19(1):141-3. PubMed ID: 15510198
[No Abstract] [Full Text] [Related]
39. Point mutations in the FLT3 gene in AML.
Griffin JD
Blood; 2001 Apr; 97(8):2193A-2193. PubMed ID: 11290575
[No Abstract] [Full Text] [Related]
40. Simplified capillary electrophoresis detection of the Flt-3 internal tandem duplications and D835 point mutations in acute myeloid leukemia.
Chang TL; Salto-Tellez M; Kueh YK; Koay ES
Haematologica; 2003 Feb; 88(2):ELT04. PubMed ID: 12604435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
